These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 235826)

  • 1. The thyroid in ulcerative colitis and Crohn's disease. I. Thyroid radioiodide uptake and urinary iodine excretion.
    Järnerot G
    Acta Med Scand; 1975; 197(1-2):77-81. PubMed ID: 235826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The thyroid in ulcreative colitis and Crohn's disease. III. The daily fractional turnover of thyroxine.
    Järnerot G; Truelove SC; Warner GT
    Acta Med Scand; 1975; 197(1-2):89-94. PubMed ID: 47700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal radioiodide excretion following intravenous injection of 131-I-albumin and 125-I-immunoglobulin G in chronic inflammatory bowel disease. An aid to topographic diagnosis.
    Jarnum S; Jensen KB
    Gastroenterology; 1975 Jun; 68(6):1433-44. PubMed ID: 1132626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The thyroid in ulverative colitis and Crohn's disease. II. Thyroid enlargement and hyperthyroidism in ulcerative colitis.
    Järnerot G; Azad Khan AK; Truelove SC
    Acta Med Scand; 1975; 197(1-2):83-7. PubMed ID: 1124663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease.
    Winterkamp S; Weidenhiller M; Otte P; Stolper J; Schwab D; Hahn EG; Raithel M
    Am J Gastroenterol; 2002 Dec; 97(12):3071-7. PubMed ID: 12492192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is plasma level monitoring of sulfasalazine indicated in the treatment of Crohn's disease or ulcerative colitis?
    Fischer C; Klotz U
    Ther Drug Monit; 1980; 2(2):153-8. PubMed ID: 6132473
    [No Abstract]   [Full Text] [Related]  

  • 8. Urinary gonadotrophin excretion in patients with ulcerative colitis and Crohn's disease treated with A.C.T.H. and corticosteroids.
    Crean GP; Loraine JA; Bell ET; Card WI; Sircus W
    Gut; 1966 Dec; 7(6):597-605. PubMed ID: 4289244
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of fecal granulocyte excretion in ulcerative colitis and Crohn's colitis.
    Saverymuttu SH; Hodgson HJ; Chadwick VS
    Dig Dis Sci; 1984 Nov; 29(11):1000-4. PubMed ID: 6489079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylation polymorphism of sulfapyridine in patients with ulcerative colitis and Crohn's disease.
    Das KM; Eastwood MA
    Clin Pharmacol Ther; 1975 Nov; 18(5 Pt 1):514-20. PubMed ID: 241531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption of delayed-release prednisolone in ulcerative colitis and Crohn's disease.
    Thomas P; Richards D; Richards A; Rogers L; Evans BK; Dew MJ; Rhodes J
    J Pharm Pharmacol; 1985 Oct; 37(10):757-8. PubMed ID: 2867153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal permeability compared in pediatric and adult patients with inflammatory bowel disease.
    Issenman RM; Jenkins RT; Radoja C
    Clin Invest Med; 1993 Jun; 16(3):187-96. PubMed ID: 8365046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal permeability to 99mTc-diethylenetriaminopentaacetic acid in inflammatory bowel disease.
    Casellas F; Aguadé S; Soriano B; Accarino A; Molero J; Guarner L
    Am J Gastroenterol; 1986 Sep; 81(9):767-70. PubMed ID: 3529937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
    Daig R; Andus T; Aschenbrenner E; Falk W; Schölmerich J; Gross V
    Gut; 1996 Feb; 38(2):216-22. PubMed ID: 8801200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary patterns of patients with renal stones associated with chronic inflammatory bowel disease.
    Trinchieri A; Lizzano R; Castelnuovo C; Zanetti G; Pisani E
    Arch Ital Urol Androl; 2002 Jun; 74(2):61-4. PubMed ID: 12161938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary crystalloid excretion in patients with inflammatory bowel disease.
    Breuer RI; Gelzayd EA; Kirsner JK
    Gut; 1970 Apr; 11(4):314-8. PubMed ID: 5428854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [5-Aminosalicylic acid in ulcerative colitis and Crohn's disease (author's transl)].
    Maier K; Fischer C; Klotz U; Heinkel K
    Dtsch Med Wochenschr; 1982 Jul; 107(29-30):1131-4. PubMed ID: 6123426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of drug therapy for inflammatory bowel disease.
    Peppercorn MA
    Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study.
    Stallmach A; Langbein C; Atreya R; Bruns T; Dignass A; Ende K; Hampe J; Hartmann F; Neurath MF; Maul J; Preiss JC; Schmelz R; Siegmund B; Schulze H; Teich N; von Arnim U; Baumgart DC; Schmidt C
    Aliment Pharmacol Ther; 2016 Dec; 44(11-12):1199-1212. PubMed ID: 27714831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BODY COMPOSITION IN PATIENTS WITH CROHN'S DISEASE AND ULCERATIVE COLITIS.
    Back IR; Marcon SS; Gaino NM; Vulcano DSB; Dorna MS; Sassaki LY
    Arq Gastroenterol; 2017; 54(2):109-114. PubMed ID: 28198913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.